Folger Nolan Fleming Douglas Capital Management Inc. Makes New Investment in Cigna Group $CI

Posted by Francis Steltz on Jun 30th, 2026

Folger Nolan Fleming Douglas Capital Management Inc. purchased a new stake in Cigna Group (NYSE:CI – Free Report) during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm purchased 3,521 shares of the health services provider’s stock, valued at approximately $939,000.

A number of other large investors have also recently modified their holdings of CI. Cary Street Partners Investment Advisory LLC raised its stake in Cigna Group by 11.0% in the fourth quarter. Cary Street Partners Investment Advisory LLC now owns 363 shares of the health services provider’s stock valued at $100,000 after purchasing an additional 36 shares in the last quarter. OLD National Bancorp IN lifted its position in Cigna Group by 3.7% during the fourth quarter. OLD National Bancorp IN now owns 1,031 shares of the health services provider’s stock valued at $284,000 after purchasing an additional 37 shares during the last quarter. IHT Wealth Management LLC grew its stake in Cigna Group by 2.5% in the 4th quarter. IHT Wealth Management LLC now owns 1,535 shares of the health services provider’s stock worth $423,000 after buying an additional 38 shares in the last quarter. Whetstone Capital Advisors LLC grew its stake in Cigna Group by 4.9% in the 4th quarter. Whetstone Capital Advisors LLC now owns 829 shares of the health services provider’s stock worth $228,000 after buying an additional 39 shares in the last quarter. Finally, CYBER HORNET ETFs LLC increased its holdings in shares of Cigna Group by 5.3% in the 4th quarter. CYBER HORNET ETFs LLC now owns 801 shares of the health services provider’s stock worth $220,000 after buying an additional 40 shares during the last quarter. Institutional investors own 86.99% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms have recently weighed in on CI. Morgan Stanley raised their price objective on shares of Cigna Group from $355.00 to $361.00 and gave the company an “overweight” rating in a research report on Wednesday, May 20th. Jefferies Financial Group cut their target price on shares of Cigna Group from $333.00 to $330.00 and set a “buy” rating for the company in a research report on Monday, April 20th. Cantor Fitzgerald increased their target price on Cigna Group from $325.00 to $340.00 and gave the company an “overweight” rating in a research note on Friday, May 1st. Mizuho raised their price target on Cigna Group from $330.00 to $340.00 and gave the company an “outperform” rating in a research report on Monday, June 8th. Finally, UBS Group lifted their price target on Cigna Group from $375.00 to $400.00 and gave the stock a “buy” rating in a research note on Friday, May 22nd. One investment analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and six have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $338.30.

Get Our Latest Analysis on CI

Insider Transactions at Cigna Group

In related news, CAO Jamie G. Kates sold 899 shares of the stock in a transaction dated Friday, June 12th. The stock was sold at an average price of $298.61, for a total transaction of $268,450.39. Following the completion of the sale, the chief accounting officer directly owned 2,368 shares in the company, valued at $707,108.48. This represents a 27.52% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, CEO David Cordani sold 201,878 shares of the firm’s stock in a transaction that occurred on Tuesday, May 12th. The stock was sold at an average price of $292.82, for a total value of $59,113,915.96. Following the transaction, the chief executive officer owned 34,337 shares in the company, valued at approximately $10,054,560.34. The trade was a 85.46% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.60% of the stock is currently owned by company insiders.

Cigna Group Trading Down 1.2%

CI stock opened at $279.35 on Tuesday. The company has a market capitalization of $73.90 billion, a PE ratio of 11.84, a price-to-earnings-growth ratio of 1.09 and a beta of 0.28. Cigna Group has a one year low of $239.51 and a one year high of $338.89. The company’s 50 day moving average price is $284.72 and its two-hundred day moving average price is $278.96. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.73 and a current ratio of 0.73.

Cigna Group (NYSE:CI – Get Free Report) last announced its quarterly earnings data on Thursday, April 30th. The health services provider reported $7.79 earnings per share for the quarter, topping analysts’ consensus estimates of $7.60 by $0.19. Cigna Group had a net margin of 2.26% and a return on equity of 19.75%. The firm had revenue of $68.52 billion during the quarter, compared to analyst estimates of $66.29 billion. During the same period in the previous year, the business posted $6.74 EPS. The business’s quarterly revenue was up 4.6% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.350- EPS. As a group, analysts predict that Cigna Group will post 30.39 earnings per share for the current fiscal year.

Cigna Group Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Thursday, June 18th. Shareholders of record on Thursday, June 4th were paid a $1.56 dividend. The ex-dividend date of this dividend was Thursday, June 4th. This represents a $6.24 annualized dividend and a yield of 2.2%. Cigna Group’s payout ratio is currently 26.45%.

About Cigna Group

(Free Report)

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.